Therapeutic Asset Ratings
414 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Naproxen
Colorectal Cancer
M.D. Anderson Cancer Center
P2
CC
(46)
Navicixizumab
Colorectal Cancer
OncXerna Theraputics, Inc.
P2
CC
(46)
Neoantigen Dendritic Cell Vaccine
Colorectal Cancer
National Cancer Centre, Singapore
P2
CC
(46)
Nocardia Rubra Cell Wall Skeleton
Colorectal Cancer
Sun Jing
P2
CC
(46)
Pd-L1 T-Hank
Colorectal Cancer
ImmunityBio, Inc.
P2
CC
(46)
Poloxamer 188
Colorectal Cancer
The Second Hospital of Nanjing Medical University
P2
CC
(46)
Qbeco
Colorectal Cancer
Sunnybrook Health Sciences Centre
P2
CC
(46)
Recombinant Mutant Human Tumor Necrosis Factor
Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
P2
CC
(46)
Rilvegostomig
Colorectal Cancer
AstraZeneca
P2
CC
(46)
Romiplostim
Colorectal Cancer
Peking University People's Hospital
P2
CC
(46)
Shr-3821
Colorectal Cancer
Meng Qiu
P2
CC
(46)
Si-B001
Colorectal Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
P2
CC
(46)
Si-B003
Colorectal Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
P2
CC
(46)
Tovecimig
Colorectal Cancer
Washington University School of Medicine
P2
CC
(46)
Vesanoid
Colorectal Cancer
Peking University People's Hospital
P2
CC
(46)
Vibostolimab
Colorectal Cancer
Merck Sharp & Dohme LLC
P2
CC
(46)
Volrustomig
Colorectal Cancer
AstraZeneca
P2
CC
(46)
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL CAN04 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CAN04 .KAPPA.-CHAIN, DIMER
Colorectal Cancer
Cantargia AB
P1/2
CC
(46)
TEMUTERKIB
Colorectal Cancer
The Netherlands Cancer Institute
P1/2
CC
(46)
n-803
Colorectal Cancer
National Cancer Institute (NCI)
P2
CC
(45)
Cea Car-T Cells
Colorectal Cancer
Weijia Fang, MD
P1/2
CC
(45)
Eribulin
Colorectal Cancer
Enliven Therapeutics
P1/2
CC
(45)
FULVESTRANT
Colorectal Cancer
Pfizer
P1/2
CC
(45)
LEUPROLIDE
Colorectal Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
P1/2
CC
(45)
Rmc-9805
Colorectal Cancer
Revolution Medicines, Inc.
P1/2
CC
(45)
Showing 151 to 175 of 414 assets
Previous
Page 7 of 17
Next
